STRS Ohio’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

STRS Ohio’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$52.4M	Buy	410,500 +19,300	+5%	+$2.41M	0.21%	103
2025 Q4	$47.7M	Sell	391,200 -13,800	-3%	-$1.58M	0.18%	111
2025 Q3	$40.6M	Buy	405,000 +25,100	+7%	+$2.26M	0.15%	138
2025 Q2	$31.5M	Buy	379,900 +37,100	+11%	+$2.96M	0.12%	188
2025 Q1	$27.8M	Hold	342,800	–	–	0.12%	200
2024 Q4	$30.9M	Sell	342,800 -77,500	-18%	-$7.51M	0.12%	190
2024 Q3	$41.5M	Buy	420,300 +40,600	+11%	+$3.99M	0.16%	148
2024 Q2	$35.2M	Buy	379,700 +21,700	+6%	+$1.95M	0.14%	164
2024 Q1	$34M	Buy	358,000 +37,700	+12%	+$3.5M	0.14%	181
2023 Q4	$28.6M	Buy	320,300 +17,900	+6%	+$1.33M	0.12%	202
2023 Q3	$22.1M	Buy	302,400 +38,300	+15%	+$3.06M	0.1%	231
2023 Q2	$22M	Buy	264,100 +27,000	+11%	+$2.26M	0.09%	240
2023 Q1	$18.1M	Sell	237,100 -31,800	-12%	-$2.64M	0.08%	279
2022 Q4	$22.3M	Buy	268,900 +51,400	+24%	+$4.16M	0.1%	250
2022 Q3	$17.3M	Buy	217,500 +60,100	+38%	+$5.07M	0.08%	272
2022 Q2	$11.7M	Sell	157,400 -5,600	-3%	-$420K	0.05%	343
2022 Q1	$14.7M	Buy	163,000 +41,000	+34%	+$3.79M	0.05%	339
2021 Q4	$13.7M	Buy	122,000 +15,000	+14%	+$1.81M	0.05%	359
2021 Q3	$13.4M	Buy	107,000 +2,200	+2%	+$283K	0.05%	358
2021 Q2	$14.2M	Sell	104,800 -10,000	-9%	-$1.31M	0.05%	346
2021 Q1	$15.6M	Sell	114,800 -137,000	-54%	-$20.5M	0.06%	317
2020 Q4	$35.4M	Buy	251,800 +25,000	+11%	+$3.2M	0.14%	188
2020 Q3	$25.3M	Buy	226,800 +161,000	+245%	+$18M	0.11%	221
2020 Q2	$7.37M	Buy	65,800 +15,000	+30%	+$1.48M	0.03%	377
2020 Q1	$3.93M	Buy	50,800 +7,900	+18%	+$700K	0.02%	434
2019 Q4	$4.08M	Sell	42,900 -5,100	-11%	-$441K	0.02%	512
2019 Q3	$3.66M	Hold	48,000	–	–	0.02%	514
2019 Q2	$4.21M	Sell	48,000 -2,000	-4%	-$171K	0.02%	489
2019 Q1	$4.53M	Hold	50,000	–	–	0.02%	475
2018 Q4	$3.59M	Buy	50,000 +5,000	+11%	+$403K	0.02%	506
2018 Q3	$4.31M	Buy	45,000 +2,000	+5%	+$194K	0.02%	493
2018 Q2	$4.09M	Buy	43,000 +1,000	+2%	+$91.9K	0.02%	528
2018 Q1	$3.68M	Buy	42,000 +4,000	+11%	+$365K	0.02%	534
2017 Q4	$3.23M	Buy	38,000 +3,000	+9%	+$251K	0.01%	565
2017 Q3	$3.03M	Sell	35,000 -25,000	-42%	-$2M	0.01%	575
2017 Q2	$4.63M	Hold	60,000	–	–	0.02%	491
2017 Q1	$4.16M	Hold	60,000	–	–	0.02%	543
2016 Q4	$3.55M	Hold	60,000	–	–	0.02%	573
2016 Q3	$3.98M	Hold	60,000	–	–	0.02%	544
2016 Q2	$3.25M	Buy	+60,000	New	+$3.29M	0.01%	564

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

STRS Ohio's XBI Position: Q1 2026 in Review

STRS Ohio increased its State Street SPDR S&P Biotech ETF (XBI) stake by 4.9% in Q1 2026, buying an estimated $2.41M and bringing the position to 410,500 shares worth $52.4M. The position accounts for 0.21% of the portfolio, ranked #103.

STRS Ohio first reported a position in XBI in Q2 2016 and has held it in 40 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

STRS Ohio held 410,500 shares of State Street SPDR S&P Biotech ETF worth $52.4M as of Q1 2026.
STRS Ohio bought 19,300 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $2.41M.
State Street SPDR S&P Biotech ETF made up 0.21% of STRS Ohio's portfolio in Q1 2026, its #103 holding.
STRS Ohio first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and has held it in 40 quarters since.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.